Dr. Hines is a triple board-certified interventional pain physician and former state president of the North Carolina American Society of Interventional Pain Physicians. Mark has over 25 years of experience in the medical industry with a particular focus in biopharmaceuticals, developing early stage, novel technologies tailored towards drug and nutraceutical development across multiple therapeutic areas, especially those that treat pain and metabolic comorbidities. He is co-principal of Mingowood Pharmacal and Vice President of Product Development. He also serves as the Co-Founder of SleepFlow, LLC, a healthcare technology implementation company bringing new sleep options for rapid market expansion; the CEO of Intersect Partners, LLC, specializing in complementary Med-Tech solutions; as well as the CEO of Venturix, LLC, a venture capital firm for accredited and non-accredited investors seeking capital growth through new medical technologies and pharmaceuticals. He has a deep interest in finding new and innovative medical discoveries destined to make large impacts in healthcare and source funding for several startups in the biotechnology space.